The Effect of Alcohol on ABCA1 Expression and Lipid Metabolism

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00558935

Enrollment

Registered

2007-11-16

Start date

2007-10-31

Completion date

2008-12-31

Last updated

2011-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes, Heart Disease

Brief summary

The purpose of this study is to investigate the effects of red wine on ABCA1 levels

Interventions

DIETARY_SUPPLEMENTRed Wine

20g alcohol daily/red wine for 4 weeks

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

PREVENTION

Masking

TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender

MALE

Age

18 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Healthy participants * Aged 18-65 years * Free of overt coronary disease * BMI \< 35 * Fasting plasma glucose \<6.1 mmol * Unmedicated * No major illness

Exclusion criteria

* Unable to give informed consent * Smokers * Participants with alcoholism

Design outcomes

Primary

Measure	Time frame
measurements of dyslipidemia	2 years

Secondary

Measure	Time frame
lipid functionality	2 years

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026